Nir3 Inhibitors
Nir3 inhibitors are a class of chemical compounds designed to selectively modulate protein-protein interactions within cellular signaling pathways. These inhibitors are often characterized by their ability to interfere with specific molecular targets involved in transcriptional regulation, particularly in response to stress or environmental changes. The "Nir3" designation refers to a distinct group of small molecules that bind to certain regulatory proteins, thereby modulating their function and potentially influencing various intracellular processes. Nir3 inhibitors typically feature a core scaffold that allows for high-affinity binding to their target proteins, with modifications made to improve specificity, solubility, and stability. These inhibitors are often used as research tools to dissect complex molecular mechanisms, allowing scientists to better understand signaling pathways and the effects of various proteins on cell function.
In terms of structure-activity relationships, Nir3 inhibitors often contain hydrophobic regions that enable them to interact with nonpolar pockets on target proteins, as well as polar groups that engage in hydrogen bonding. These chemical features contribute to their binding efficiency and selectivity. Nir3 inhibitors may also possess flexible linkers that enable them to adopt conformations that fit the three-dimensional structure of their target. Due to their molecular versatility, these compounds can be fine-tuned for a variety of biochemical studies aimed at elucidating the intricacies of cellular regulation. Their design and development often rely on high-throughput screening and computational modeling to identify potential candidates with optimal binding properties.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium carbonate could deplete inositol pools by inhibiting inositol monophosphatase, likely leading to a downregulation of phosphatidylinositol signaling and subsequent decrease in Nir3 expression. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
Wortmannin, a potent PI3K inhibitor, may disrupt the PI3K/Akt pathway, leading to a consequential decrease in cell survival signals that would otherwise upregulate Nir3 expression. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
LY 294002 specifically targets and inhibits PI3K, potentially resulting in a diminished PI3K/Akt pathway activity and a decrease in Nir3 expression due to reduced cellular proliferation. | ||||||
Simvastatin | 79902-63-9 | sc-200829 sc-200829A sc-200829B sc-200829C | 50 mg 250 mg 1 g 5 g | $30.00 $87.00 $132.00 $434.00 | 13 | |
Simvastatin's primary action in reducing cholesterol biosynthesis may secondarily reduce membrane fluidity and associated signaling pathways, potentially culminating in decreased Nir3 expression. | ||||||
Lovastatin | 75330-75-5 | sc-200850 sc-200850A sc-200850B | 5 mg 25 mg 100 mg | $28.00 $88.00 $332.00 | 12 | |
Lovastatin's inhibition of HMG-CoA reductase is known to lower cholesterol levels, which might lead to a reduced availability of lipid rafts, thereby downregulating Nir3 expression. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
Trichostatin A prevents histone deacetylase activity, potentially leading to hyperacetylation of histones, chromatin relaxation, and the subsequent downregulation of specific genes, including possibly Nir3. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
By inhibiting DNA methyltransferase, 5-Azacytidine may cause hypomethylation of DNA and alter gene expression patterns, which could include the downregulation of Nir3 expression. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Rapamycin binds to mTOR complex 1 and inhibits its activity, which could lead to a reduced rate of cell growth and protein synthesis, potentially resulting in the downregulation of Nir3 expression. | ||||||
Tamoxifen | 10540-29-1 | sc-208414 | 2.5 g | $256.00 | 18 | |
Tamoxifen, as an estrogen receptor antagonist in breast tissue, could disrupt estrogen-mediated transcription processes, potentially leading to decreased Nir3 expression if Nir3 is estrogen-responsive. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $65.00 $319.00 $575.00 $998.00 | 28 | |
Retinoic acid, through its interaction with retinoic acid receptors, may induce gene expression changes that promote differentiation and concomitantly inhibit Nir3 expression. | ||||||